Blockchain Registration Transaction Record

TAG1 Inc. to Join Expert Panel at Jones Las Vegas Technology Conference

Explore how TAG1 Inc. leads the way in cancer treatment innovation at the Jones Las Vegas Technology and Innovation Conference. Learn about the company's contributions to the radiopharmaceutical industry and the critical role of Lead-212 in targeted alpha therapies.

This news highlights TAG1 Inc.'s role in advancing cancer treatment through innovative radioisotope technologies. Participation in the conference provides a platform for the company to showcase its progress, meet with investors, and contribute to discussions on the future of radiopharmaceuticals. The event underscores the importance of strengthening the supply chain for targeted alpha therapies to meet the growing clinical demand for critical isotopes.